Bryan Brewer

5.3k total citations · 1 hit paper
19 papers, 4.1k citations indexed

About

Bryan Brewer is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Bryan Brewer has authored 19 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Surgery and 6 papers in Oncology. Recurrent topics in Bryan Brewer's work include Cholesterol and Lipid Metabolism (8 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Lipoproteins and Cardiovascular Health (4 papers). Bryan Brewer is often cited by papers focused on Cholesterol and Lipid Metabolism (8 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Lipoproteins and Cardiovascular Health (4 papers). Bryan Brewer collaborates with scholars based in United States, France and Australia. Bryan Brewer's co-authors include Mark J. Caulfield, Michel Komajda, José López‐Sendón, John J.P. Kastelein, Lori Mosca, Jean‐Claude Tardif, Charles L. Shear, Marian R. Fisher, Kevin A. Buhr and Mats Eriksson and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.

In The Last Decade

Bryan Brewer

19 papers receiving 4.0k citations

Hit Papers

Effects of Torcetrapib in Patients at High Risk for Coron... 2007 2026 2013 2019 2007 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryan Brewer United States 15 2.0k 1.6k 1.3k 787 736 19 4.1k
John R. Burnett Australia 36 2.5k 1.2× 1.3k 0.8× 1.3k 1.0× 956 1.2× 443 0.6× 164 4.6k
Jerzy–Roch Nofer Germany 36 2.0k 1.0× 1.3k 0.8× 2.0k 1.6× 723 0.9× 417 0.6× 104 5.0k
Heiner Greten Germany 33 3.2k 1.6× 1.7k 1.0× 824 0.7× 1.2k 1.6× 555 0.8× 78 5.3k
Marian C. Cheung United States 38 3.0k 1.5× 3.2k 2.0× 1.3k 1.0× 930 1.2× 631 0.9× 74 5.9k
Shui‐Ping Zhao China 35 1.5k 0.7× 1.0k 0.6× 1.0k 0.8× 1.2k 1.5× 722 1.0× 235 4.3k
Loren A. Zech United States 39 2.5k 1.2× 2.3k 1.4× 1.2k 1.0× 991 1.3× 450 0.6× 91 4.8k
Megan L. Wolfe United States 31 1.9k 0.9× 1.7k 1.1× 785 0.6× 1.3k 1.7× 1.4k 1.9× 53 4.8k
Akihiro Inazu Japan 38 3.1k 1.5× 2.1k 1.3× 1.0k 0.8× 1.0k 1.3× 379 0.5× 136 4.9k
Armin Steinmetz Germany 34 3.1k 1.5× 2.6k 1.6× 1.6k 1.3× 858 1.1× 377 0.5× 112 5.2k
E. Windler Germany 25 1.2k 0.6× 1.3k 0.8× 807 0.6× 569 0.7× 506 0.7× 82 3.1k

Countries citing papers authored by Bryan Brewer

Since Specialization
Citations

This map shows the geographic impact of Bryan Brewer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Brewer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Brewer more than expected).

Fields of papers citing papers by Bryan Brewer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan Brewer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Brewer. The network helps show where Bryan Brewer may publish in the future.

Co-authorship network of co-authors of Bryan Brewer

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan Brewer. A scholar is included among the top collaborators of Bryan Brewer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan Brewer. Bryan Brewer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Menon, Venu, A. Michael Lincoff, Stephen J. Nicholls, et al.. (2017). 3911Impact of CETP inhibition with evacetrapib in patients with diabetes mellitus: results from ACCELERATE. European Heart Journal. 38(suppl_1). 1 indexed citations
3.
Wang, Jun, S. Gary Mansfield, Colette Côté, et al.. (2008). Trans-splicing Into Highly Abundant Albumin Transcripts for Production of Therapeutic Proteins In Vivo. Molecular Therapy. 17(2). 343–351. 17 indexed citations
4.
Barter, Philip J., Mark J. Caulfield, Mats Eriksson, et al.. (2007). Effects of Torcetrapib in Patients at High Risk for Coronary Events. New England Journal of Medicine. 357(21). 2109–2122. 2218 indexed citations breakdown →
5.
Guo, Grace L., Silvia Santamarina-Fojo, Taro E. Akiyama, et al.. (2006). Effects of FXR in foam-cell formation and atherosclerosis development. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1761(12). 1401–1409. 111 indexed citations
6.
Fruchart‐Najib, Jamila, Eric Baugé, Loredan S. Niculescu, et al.. (2004). Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5. Biochemical and Biophysical Research Communications. 319(2). 397–404. 173 indexed citations
7.
Arakawa, Reijiro, Michi Hayashi, Alan T. Remaley, et al.. (2004). Phosphorylation and Stabilization of ATP Binding Cassette Transporter A1 by Synthetic Amphiphilic Helical Peptides. Journal of Biological Chemistry. 279(8). 6217–6220. 66 indexed citations
8.
Matsusue, Kimihiko, Martin Haluzı́k, Gilles Lambert, et al.. (2003). Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. Journal of Clinical Investigation. 111(5). 737–747. 476 indexed citations
9.
Matsusue, Kimihiko, Martin Haluzı́k, Gilles Lambert, et al.. (2003). Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. Journal of Clinical Investigation. 111(5). 737–747. 478 indexed citations
10.
Bérard, Annie M., Michel Clerc, Bryan Brewer, & Silvia Santamarina-Fojo. (2001). A normal rate of cellular cholesterol removal can be mediated by plasma from a patient with familial lecithin–cholesterol acyltransferase (LCAT) deficiency. Clinica Chimica Acta. 314(1-2). 131–139. 14 indexed citations
11.
Shulenin, Sergey, Lynn M. Schriml, Alan T. Remaley, et al.. (2001). An ATP-binding cassette gene (ABCG5) from the ABCG (White) gene subfamily maps to human chromosome 2p21 in the region of the Sitosterolemia locus. Cytogenetic and Genome Research. 92(3-4). 204–208. 24 indexed citations
12.
Lee, Mi‐Hye, Derek Gordon, Jürg Ott, et al.. (2001). Fine mapping of a gene responsible for regulating dietary cholesterol absorption; founder effects underlie cases of phytosterolaemia in multiple communities. European Journal of Human Genetics. 9(5). 375–384. 29 indexed citations
13.
Sloand, Elaine M., Jaroslaw P. Maciejewski, Daniel E. Dunn, et al.. (1998). Correction of the PNH Defect by GPI-Anchored Protein Transfer. Blood. 92(11). 4439–4445. 6 indexed citations
14.
Sloand, Elaine M., Jaroslaw P. Maciejewski, Daniel E. Dunn, et al.. (1998). Correction of the PNH Defect by GPI-Anchored Protein Transfer. Blood. 92(11). 4439–4445. 49 indexed citations
15.
Schmidt, Hartmut, et al.. (1997). Erdheim-chester disease: Low low-density lipoprotein levels due to rapid catabolism. Metabolism. 46(10). 1215–1219. 23 indexed citations
16.
Kounnas, Maria Z., Elena Loukinova, Steingrimur Stefansson, et al.. (1995). Identification of Glycoprotein 330 as an Endocytic Receptor for Apolipoprotein J/Clusterin. Journal of Biological Chemistry. 270(22). 13070–13075. 196 indexed citations
17.
Kounnas, Maria Z., Elena Loukinova, Steingrimur Stefansson, et al.. (1995). Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin.. Journal of Biological Chemistry. 270(39). 23234a–23234a. 8 indexed citations
19.
Gwynne, John T., Bryan Brewer, & Harold Edelhoch. (1974). The Molecular Properties of ApoA-I from Human High Density Lipoprotein. Journal of Biological Chemistry. 249(8). 2411–2416. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026